We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Elizabeth (Beth) Halpern

Hogan Lovells

Results 1 to 5 of 37
Most popular |Most recent


Regulatory Insights for Life Sciences and Health Care Investments: Drug Pricing and Reimbursement

USA - November 29 2018 Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure...

Margaux J. Hall, Alice Valder Curran, Christopher H. Schott.


Medicare further expands payment for and coverage of telehealth and similar services

USA - November 7 2018 Through several recently published rules, the Centers for Medicare & Medicaid Services (CMS) is making it possible for Medicare beneficiaries to have...

Ken Choe, Thomas Beimers, Sheree R. Kanner, Beth L. Roberts, Craig H. Smith, Brooke Bumpers.


CMS considers linking Medicare drug payment rates to international prices

USA - October 30 2018 On October 25, 2018, the Centers for Medicare & Medicaid Services (CMS) issued an Advance Notice of Proposed Rulemaking (ANPRM) describing a potential...

Ken Choe, Ali Lakhani, Margaux J. Hall, Kathleen A. Peterson, Samantha D. Marshall, Beth L. Roberts, Alice Valder Curran, Christopher H. Schott, Stuart M. Langbein.


Trump touts “historic” plan to overhaul Medicare payments, create International Pricing Index

USA - October 25 2018 President Trump today touted “bold” plans to lower drug prices in unspecific terms. Simultaneously, CMS issued an Advance Notice of Proposed...

Ken Choe, Beth L. Roberts, Alice Valder Curran, Stuart M. Langbein.


CMS proposes requiring drug prices in TV ads

USA - October 23 2018 On October 15, CMS released a proposed rule titled “Medicare and Medicaid Programs: Drug Pricing Transparency,” which would require direct-to-consumer...

Meredith Manning, Beth L. Roberts.